RNA Splicing: Basic Aspects Underlie Antitumor Targeting

Author(s): Alzahraa A.M. Fergany*, Victor V. Tatarskiy

Journal Name: Recent Patents on Anti-Cancer Drug Discovery

Volume 15 , Issue 4 , 2020

Become EABM
Become Reviewer


Background: RNA splicing, a fundamental step in gene expression, is aimed at intron removal and ordering of exons to form the protein’s reading frame.

Objective: This review is focused on the role of RNA splicing in cancer biology; the splicing abnormalities that lead to tumor progression emerge as targets for therapeutic intervention.

Methods: We discuss the role of aberrant mRNA splicing in carcinogenesis and drug response.

Results and Conclusion: Pharmacological modulation of RNA splicing sets the stage for treatment approaches in situations where mRNA splicing is a clinically meaningful mechanism of the disease.

Keywords: Cancer, molecular drug targets, RNA splicing, therapy, protein kinase inhibitors.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Published on: 29 December, 2020
Page: [293 - 305]
Pages: 13
DOI: 10.2174/1574892815666200908122402
Price: $65

Article Metrics

PDF: 17